SCHEMBL23715053

SCHEMBL23715053

CC1(OSI)COCc2c(F)cc(Br)cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23705070 0.82 NR3C1 (0.30) —
SCHEMBL25497844 0.78 NR3C1 (0.33) —
SCHEMBL23704798 0.76 NR3C1 (0.32) —
SCHEMBL23704874 0.72 NR3C1 (0.31) —
SCHEMBL23715054 0.67 — —
SCHEMBL23714873 0.64 MAPK1 (0.30) —
SCHEMBL28988481 0.60 PRKCG (0.32) —
SCHEMBL10440200 0.60 NR3C1 (0.35) —
SCHEMBL32691431 0.60 BACE1 (0.31) —
SCHEMBL23714685 0.60 CHRNA1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021155316-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2021-08-05 — — WO disclosed
Send feedback